Skip to main content
. Author manuscript; available in PMC: 2017 Oct 11.
Published in final edited form as: Lancet Oncol. 2017 Feb 3;18(3):393–403. doi: 10.1016/S1470-2045(17)30015-3

Table 5.

Summary of change from baseline in HRQoL score at Week 10 by Treatment and AE Status at week 10 visit.

Placebo Ipilimumab
AE absent AE present AE absent AE present
Diarrhea
Mean (SD) −1.34 (14.66) 14.35 (30.98) 5.21 (20.40) 23.08 (39.34)
N obs 324 79 224 130
Appetite loss
Mean (SD) 1.66 (14.63) 22.22 (27.22) 7.84 (23.35) 18.33 (33.29)
N obs 401 6 336 20
Fatigue
Mean (SD) 1.83 (17.09) 11.39 (20.34) 8.65 (22.40) 16.62 (27.25)
N obs 309 98 239 119
Insomnia
Mean (SD) −3.35 (24.01) 14.81 (55.56) 7.43 (27.48) 4.17 (36.26)
N obs 398 9 341 16
Nausea/vomiting
Mean (SD) 0.42 (6.68) 15.41 (21.40) 3.88 (14.10) 20.45 (27.70)
N obs 354 53 292 66